Search

everythinglearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Bicalutamide improves hair density in women safely.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Upadacitinib effectively treats pyoderma gangrenosum.

The new adapalene formulation using TyroSpheres is more effective and less irritating for acne treatment.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Sulphadiazine can cause crystals to form in urine.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Tislelizumab can cause cutaneous lupus erythematosus.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

The diphosphonate was the most effective at preventing calcification in rats.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.